| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.094 | 0.1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.092 | 0.1 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |